SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW
Scilex Holding Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.57−0.26 (-9.19%)
Close on Oct 19, 2026
- Market cap
- $17.71M
- P/E (TTM)
- –
- Dividend yield
- –
Scilex statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Scilex | Industry median |
|---|---|---|
| Market Cap | $21.83M | $164.85M |
| Enterprise Value | $99.90M | $87.06M |
| PS Ratio | 0.69 | 3.60 |
Enterprise value
| Measure | Scilex | Industry median |
|---|---|---|
| EV / Sales | 3.16 | 2.43 |
Income (trailing twelve months)
| Measure | Scilex | Industry median |
|---|---|---|
| Revenue | $31.61M | $57.94M |
| Gross Profit | $50.91M | $90.47M |
| Operating Income | -$359.19M | -$21.44M |
| Pretax Income | -$464.55M | -$14.45M |
| Net Income | -$464.56M | -$22.46M |
| EBITDA | -$350.88M | -$16.91M |
Margins
| Measure | Scilex | Industry median |
|---|---|---|
| Gross Margin | 161.1% | 52.3% |
| Operating Margin | -1136.4% | -44.5% |
| Pretax Margin | -1469.7% | -13.0% |
| Profit Margin | -1469.8% | -39.2% |
| EBITDA Margin | -1110.1% | -31.3% |
Returns
| Measure | Scilex | Industry median |
|---|---|---|
| Return on Assets (ROA) | -275.4% | -41.0% |
Growth
| Measure | Scilex | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -28.5% | 6.01% |
| Revenue Growth (3Y CAGR) | -7.35% | 2.25% |
| Revenue Growth (5Y CAGR) | 5.13% | 6.42% |
Balance sheet
| Measure | Scilex | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $566.00K | $62.42M |
| Total Debt | $80.81M | $120.13M |
| Net Cash (Debt) | -$80.24M | $15.68M |
| Net Cash Per Share | -$9.45 | $0.66 |
| Equity (Book Value) | -$308.32M | $48.79M |
| Book Value Per Share | -$36.30 | $1.36 |
| Tangible Book Value | -$379.41M | $23.06M |
| Working Capital | -$476.01M | $75.77M |
Financial position
| Measure | Scilex | Industry median |
|---|---|---|
| Current Ratio | 0.07 | 3.30 |
| Quick Ratio | 0.01 | 2.39 |
| Interest Coverage | -22.20 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Scilex | Industry median |
|---|---|---|
| Operating Cash Flow | -$17.09M | -$12.35M |
Efficiency
| Measure | Scilex | Industry median |
|---|---|---|
| Asset Turnover | 0.19 | 0.38 |
| Inventory Turnover | 4.21 | 2.67 |
| Revenue Per Employee | $929.65K | $398.96K |
| Profits Per Employee | -$13.66M | -$703.34K |
| Employee Count | 34 | 74 |
Dividends and yields
| Measure | Scilex | Industry median |
|---|---|---|
| Earnings Yield | -2128.4% | -22.7% |
Shares
| Measure | Scilex | Industry median |
|---|---|---|
| Shares Outstanding | 8,493,000 | 58,179,650 |
| Shares Change (QoQ) | -17.2% | 0.54% |
| Shares Held by Institutions | 9.81% | 59.4% |
Scores
| Measure | Scilex | Industry median |
|---|---|---|
| Altman Z-Score | -12.73 | -0.24 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -7.50 | -2.62 |
Calculated by StockData from Scilex's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.